Literature DB >> 16877005

Small molecule screening in the zebrafish.

R D Murphey1, L I Zon.   

Abstract

The zebrafish is an ideal organism for small molecule studies. The ability to use the whole organism allows complex in vivo phenotypes to be assayed and combines animal testing with screening. Embryos are easily treatable by waterborne exposure. The small size and abundance of embryos make zebrafish suitable for screening in a high-throughput manner in 96- or 48-well plates. Zebrafish embryos have successfully been used in chemical genetic screens to elucidate biological pathways and find chemical suppressors. Small molecules discovered by screening zebrafish disease models may also be useful as lead compounds for drug development as there appears to be a high level of conservation of drug activity between mammals and zebrafish. Here we provide the technical aspects of treating embryos with small molecules and performing chemical screens with zebrafish.

Entities:  

Mesh:

Year:  2006        PMID: 16877005     DOI: 10.1016/j.ymeth.2005.09.019

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  31 in total

1.  Inhibition of the P2X7 receptor reduces cystogenesis in PKD.

Authors:  Ming-Yang Chang; Jenn-Kan Lu; Ya-Chung Tian; Yung-Chang Chen; Cheng-Chieh Hung; Yi-Hui Huang; Yau-Hung Chen; Mai-Szu Wu; Chih-Wei Yang; Yi-Chuan Cheng
Journal:  J Am Soc Nephrol       Date:  2011-06-02       Impact factor: 10.121

Review 2.  Neurobiological applications of small molecule screening.

Authors:  Andras Bauer; Brent Stockwell
Journal:  Chem Rev       Date:  2008-05-01       Impact factor: 60.622

3.  In vivo imaging and quantitative analysis of changes in axon length using transgenic zebrafish embryos.

Authors:  Jyotshnabala Kanungo; Susan Lantz; Merle G Paule
Journal:  Neurotoxicol Teratol       Date:  2011-08-27       Impact factor: 3.763

4.  Inducible podocyte injury and proteinuria in transgenic zebrafish.

Authors:  Weibin Zhou; Friedhelm Hildebrandt
Journal:  J Am Soc Nephrol       Date:  2012-03-22       Impact factor: 10.121

5.  Hirschsprung-like disease is exacerbated by reduced de novo GMP synthesis.

Authors:  Jonathan I Lake; Olga A Tusheva; Brittany L Graham; Robert O Heuckeroth
Journal:  J Clin Invest       Date:  2013-11       Impact factor: 14.808

Review 6.  On the diabetic menu: zebrafish as a model for pancreas development and function.

Authors:  Mary D Kinkel; Victoria E Prince
Journal:  Bioessays       Date:  2009-02       Impact factor: 4.345

7.  Characterization of zebrafish larval inflammatory macrophages.

Authors:  Jonathan R Mathias; M Ernest Dodd; Kevin B Walters; Sa Kan Yoo; Erik A Ranheim; Anna Huttenlocher
Journal:  Dev Comp Immunol       Date:  2009-07-29       Impact factor: 3.636

Review 8.  Advances in zebrafish chemical screening technologies.

Authors:  Jonathan R Mathias; Meera T Saxena; Jeff S Mumm
Journal:  Future Med Chem       Date:  2012-09       Impact factor: 3.808

9.  A small molecule inhibitor of redox-regulated protein translocation into mitochondria.

Authors:  Deepa V Dabir; Samuel A Hasson; Kiyoko Setoguchi; Meghan E Johnson; Piriya Wongkongkathep; Colin J Douglas; Johannes Zimmerman; Robert Damoiseaux; Michael A Teitell; Carla M Koehler
Journal:  Dev Cell       Date:  2013-04-15       Impact factor: 12.270

10.  Accelerating the development of novel molecular imaging probes: a role for high-throughput screening.

Authors:  H Charles Manning; Adam Lander; Eliot McKinley; Nathan J Mutic
Journal:  J Nucl Med       Date:  2008-08-14       Impact factor: 10.057

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.